搜索
Quanterix Corp
QTRX添加自选
4.030USD
+0.200+5.22%
收盘 08-07 16:00（美东）报价延迟15分钟
189.84M总市值
亏损市盈率 TTM
关于 Quanterix Corp 公司
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corp 简介
公司代码QTRX
公司名称Quanterix Corp
上市日期Dec 07, 2017
CEOToloue (Masoud)
员工数量471
证券类型Ordinary Share
年结日Dec 07
公司地址900 Middlesex Turnpike
城市BILLERICA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01821
电话16173019400
网址https://www.quanterix.com/
公司代码QTRX
上市日期Dec 07, 2017
CEOToloue (Masoud)
Quanterix Corp公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
159.60K
+3.43%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
23.88K
+48.29%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
15.04K
+53.67%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
159.60K
+3.43%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
23.88K
+48.29%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
15.04K
+53.67%
常见问题
Quanterix Corp的前五大股东是谁？
Quanterix Corp 的前五大股东如下：Dr. Masoud Toloue, Ph.D.
有多少机构持有Quanterix Corp(QTRX)的股份？
截至2026Q1，共有371家机构持有Quanterix Corp的股份，合计持有的股份价值约为42.63M，占公司总股份的90.49%。与2025Q4相比，机构持股有所增加，增幅为-4982326.00。
哪个业务部门对Quanterix Corp的收入贡献最大？
在2026Q1，Product revenue业务部门对Quanterix Corp的收入贡献最大，创收92.94M，占总收入的67.03%。